|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Drug Monitoring, Buprenorphine and Naloxone, Quantitative, Urine
Test Code93094
CPT Codes
80348, 80362 (HCPCS: G0480)
Includes
Buprenorphine, Norbuprenorphine, Naloxone
Preferred Specimen
20 mL urine collected in a clinical drug test transport vial
Minimum Volume
5 mL
Other Acceptable Specimens
Urine collected in urine collection container
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Preserved samples
Methodology
Mass Spectrometry (MS)
Setup Schedule
Mon-Sat
Report Available
3 to 3 days
Clinical Significance
Patients treated with buprenorphine-naloxone co-formulation will demonstrate both naloxone and buprenorphine/norbuprenorphine drug analysis. Naloxone is not detected with buprenorphine-only use.
